Jay Hoying

Chief Scientist,

ASI Life Sciences

Topic: Rebuilding the Body: Advances in Tissue Therapeutics

Regenerative medicine — repairing or replacing cells, tissues and organs — is one of the most promising frontiers in modern medicine. But building living tissue means following the “tissue rules” that govern how cells grow, organize and function together.

New tools such as smart sensors and automated systems are helping researchers uncover and apply these rules, manufacturing therapeutic tissue faster and more precisely than ever. The result: personalized regenerative therapies that can be safely produced right where patients need them, turning a once-distant dream into a present-day reality.

Philip Magnuszewski

AI in NH

Topic: What AI Can Actually Do: Real Tools, Real Examples, Live Demonstrations

You’ve probably already used AI for something, even if you didn’t think of it that way. This session shows you how far it goes: building working things from scratch in minutes, solving real problems live and seeing what opens up when the distance between an idea and a finished thing gets a lot shorter.

Free tools and no coding experience are needed. The session will also cover how to check AI’s work, since the people who get the most out of it are the ones who know how to question it.

Christy Johnson

Director of Education and Workforce Development,

ARMI | BioFabUSA

Topic: Join the Future in Biomanufacturing: Education and Career Pathways

As part of ARMI | BioFabUSA’s mission, the Education and Workforce Development Team is working to build the U.S. biomanufacturing workforce and connect learners with careers in this new and impactful industry.

ARMI | BioFabUSA’s programs provide engaging, hands-on activities and professional training with embedded industry credentials designed to inspire learners to advance their critical thinking, creativity and collaboration skills—and become the problem-solvers and innovators of tomorrow.

The Education and Workforce Development Team and its academic partners offer a variety of engaging pathways, ensuring accessibility and impact for all.

Janice M. Moser, Ph.D.

CMC Lead, Safi Biotherapeutics

Topic: Reimagining the Global Blood Supply with Manufactured Red Blood Cells

Learn about Safi Biotherapeutics’ efforts to manufacture red blood cells as an alternative blood source.

Spark Academy

Speaker, time and session details coming soon.